CASI Pharmaceuticals Inc DE

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
CASI Pharmaceuticals Inc DE
CIK #0000895051
EDGAR Form CIK 2011 - 2026
10-K [0000895051]
10-Q [0000895051]
3 [0000895051]
4 [0000895051]
8-K [0000895051]
D [0000895051]
SC 13D [0000895051]
SC 13G [0000895051]
Form 13D/13G Filer Form 13D/13G Subject Filed
Consonance Capital Management LP CASI Pharmaceuticals Inc [2021-02-17]
Consonance Capital Management LP CASI Pharmaceuticals Inc [2021-02-16]
Federated Hermes Inc CASI Pharmaceuticals Inc [2021-02-12]
Li Dapeng CASI Pharmaceuticals Inc [2019-02-06]
HE Wei-Wu CASI Pharmaceuticals Inc [2018-01-12]
Wealth Strategy Holding Ltd CASI Pharmaceuticals Inc [2017-12-01]
Zhejiang Kanglaite Group Co Ltd CASI Pharmaceuticals Inc [2016-03-21]
Sparkle Byte Ltd CASI Pharmaceuticals Inc [2016-01-25]
Spectrum Pharmaceuticals Inc CASI Pharmaceuticals Inc [2014-09-26]
Sabby Management LLC Entremed Inc [2013-03-06]
View All
Form 3/4/5 Subject 2011 - 2026
CASI Pharmaceuticals Inc DE
Zukiwski Alexander A
Huang James
He Wei-Wu
Zhou Quan
Wu Yue Alexander
Salisbury Franklin Cary jr
Shrotriya Rajesh C MD
Zhang Larry
Xu Weihao
Wealth Strategy Holding Ltd
Ren Ken Keyong
Spectrum Pharmaceuticals Cayman LP
Spectrum Pharmaceuticals Inc
Li Dapeng
Hu Cynthia W
Sparkle Byte Ltd
HE Xie AI QI Investment Management Beijing Co Ltd
Snow Moon Ltd
Li Jianguang
Lin Dongliang
Yang Fei
Shong Hugo
Tianjin Jingran Management Center Limited Partnership
Chi George
Capitelli Sara B
Wu Alex
IDG-Accel China Growth Fund III Associates LP
IDG-Accel China Growth Fund GP III Associates Ltd
Ho Chi Sing
IDG-Accel China III Investors LP
IDG-Accel China Growth Fund III LP
Zhang Suyang
Mak Tak W
Ren Ken
Bush Dwight L
Hunter Cevera Jennie
Randall Mark C M
Brooks Donald S
Tarnow Michael M
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
CASI Pharmaceuticals Inc DE CASI
Common Stock
2022-09-08 Buy 33,300 $4.28 142,524
CASI Pharmaceuticals Inc DE CASI
Common Stock
2022-09-07 Buy 3,111 $4.00 12,444
CASI Pharmaceuticals Inc DE CASI
Employee Stock Option (Right to Buy) · derivative
2022-09-07 Grant 3,000 $0.00
CASI Pharmaceuticals Inc DE CASI
Common Stock
2022-09-06 Buy 19,162 $3.89 74,540
CASI Pharmaceuticals Inc DE CASI
Common Stock
2022-09-02 Buy 400 $3.74 1,496
CASI Pharmaceuticals Inc DE CASI
Common Stock
2022-09-01 Buy 11,821 $3.72 43,974
CASI Pharmaceuticals Inc DE CASI
Common Stock
2022-08-31 Buy 24,975 $3.75 93,656
CASI Pharmaceuticals Inc DE CASI
Common Stock
2022-08-26 Buy 39,527 $3.75 148,226
CASI Pharmaceuticals Inc DE CASI
Common Stock
2022-08-24 Buy 5,000 $3.75 18,750
CASI Pharmaceuticals Inc DE CASI
Common Stock
2022-08-23 Buy 40,000 $3.50 140,000
CASI Pharmaceuticals Inc DE CASI
Common Stock
2022-08-22 Buy 23,105 $3.46 79,943
CASI Pharmaceuticals Inc DE CASI
Common Stock
2022-08-19 Buy 171,116 $3.27 559,549
CASI Pharmaceuticals Inc DE CASI
Common Stock
2022-06-15 Buy 50,000 $3.18 159,000
CASI Pharmaceuticals Inc DE CASI
Common Stock
2022-06-14 Buy 2,096 $3.06 6,414
CASI Pharmaceuticals Inc DE CASI
Common Stock
2022-06-13 Buy 36,058 $2.97 107,092
CASI Pharmaceuticals Inc DE CASI
Stock Option (Right to Buy) · derivative
2022-05-25 Grant 397,419 $0.00
CASI Pharmaceuticals Inc DE CASI
Stock Option (Right to Buy) · derivative
2022-05-25 Grant 388,387 $0.00
CASI Pharmaceuticals Inc DE CASI
Stock Option (Right to Buy) · derivative
2022-05-25 Grant 388,387 $0.00
CASI Pharmaceuticals Inc DE CASI
Stock Option (Right to Buy) · derivative
2022-05-25 Grant 345,806 $0.00
CASI Pharmaceuticals Inc DE CASI
Stock Option (Right to Buy) · derivative
2022-05-25 Grant 380,645 $0.00
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com